Comparative Evaluation of the Pharmacological Activity of Fatty Aromatic Amides and Amines with a Framework Moiety and Their Non-Covalent Complexes
Animal research · 2023
- What was studied
- Mouse pharmacology experiments
- Main finding
- The camphane chlorobenzamide candidate increased treadmill performance by 23.22–25.20% after 14 days of administration. Baseline group differences complicate interpretation; the text describes convergence toward control running times. Complexation of Chlodantane, Bromantane and ADK-918 neutralized their actoprotective effects in the tested preparations; the new derivatives were classified as moderately toxic.
Study data at a glance
- Participants or experimental model
- Mouse pharmacology experiments
- Reported results
- The camphane chlorobenzamide candidate increased treadmill performance by 23.22–25.20% after 14 days of administration. Baseline group differences complicate interpretation; the text describes convergence toward control running times. Complexation of Chlodantane, Bromantane and ADK-918 neutralized their actoprotective effects in the tested preparations; the new derivatives were classified as moderately toxic.
Study limitations and source details
Study limitations
- Abstract-level animal findings do not establish human performance benefits or improved clinical safety.
- An effect at a 14-day assessment does not prove a benefit persisted for 14 days after one dose.
- The Russian and English versions are one publication, not independent replication.
Source details
Institute abstract and selected author-uploaded full-text passages checked, including the 7/14-day schedule and baseline-imbalance discussion; complete tables not independently appraised.
Sources checked
Citation
A. A. Vernigora, R. V. Brunilin, O. V. Vostrikova, et al.. Comparative Evaluation of the Pharmacological Activity of Fatty Aromatic Amides and Amines with a Framework Moiety and Their Non-Covalent Complexes Pharmaceutical Chemistry Journal. 57(4):523–534
Study source ↗ · DOI 10.1007/s11094-023-02915-z · Bibliography entry · Link to this summary
Related compounds
Chlodantane
N-(adamantan-2-yl)-4-chlorobenzamide (ADK-910), an experimental small molecule with an adamantane cage joined to a chlorobenzamide. Russian studies examined temperature stress and physical workload.
Bromantane
A synthetic adamantane drug, also called Ladasten, studied in Russian fatigue and stress research.
ADK-918
The para-bromobenzamide counterpart of Chlodantane, N-(adamantan-2-yl)-4-bromobenzamide. It is chemically distinct from Bromantane.
Camphane chlorobenzamide
An experimental chlorobenzamide designed as a structural analogue of Chlodantane. It has a camphane cage in place of Chlodantane’s adamantane cage.